Acon Biomatrix Investors I L.L.C. Financing
Acon Biomatrix Investors I, L.L.C., Limited Liability Company just submitted form D about $57.50 million equity financing. This is a new filing. Acon Biomatrix Investors I L.L.C. was able to fundraise $57.50 million. That is 100.00% of the financing offer. The total offering amount was $57.50 million. The financing form was filed on 2016-12-01. The reason for the financing was: unspecified.
Acon Biomatrix Investors I L.L.C. is based in Dc. The company’s business is Other Health Care. The form was signed by Teresa Bernstein Secretary and Assistant Treasurer. The company was incorporated in 2016. The filler’s address is: 1133 Connecticut Ave. N.W., Washington, Dc, District Of Columbia, 20036. Kenneth R. Brotman is the related person in the form and it has address: 1133 Connecticut Avenue Nw, Suite 700, Washington, Dc, District Of Columbia, 20036. Link to Acon Biomatrix Investors I L.L.C. Filing: 000114036116088364.
Analysis of Acon Biomatrix Investors I L.L.C. Offering
On average, startups in the Other Health Care sector, sell 68.60% of the total offering amount. Acon Biomatrix Investors I L.L.C. sold 100.00% of the offering. Could this mean that the trust in Acon Biomatrix Investors I L.L.C. is high? The average offering amount for companies in the Other Health Care industry is $1.16 million. The total amount raised is 4,856.90% bigger than the average for companies in the Other Health Care sector. The minimum investment for this fundraising is set at $0. If you know more about the reasons for the financing, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Acon Biomatrix Investors I L.L.C. Also
The Form D signed by Teresa Bernstein might help Acon Biomatrix Investors I, L.L.C.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.